Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

In 2013, the FTC settled with hair company Bosley over claims it illegally shared business information with a competitor.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Follicle Stimulating Hormone is important for fertility.

Alternating treatment with two drugs could help cells in a rapid aging disease.

Certain genetic factors may contribute to frontal fibrosing alopecia in Brazil.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

People with Birt-Hogg-Dubé syndrome often have lung problems and delayed diagnosis, and better recognition of CT scan signs could improve diagnosis and management.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

A man with kidney tumors and lung cysts was diagnosed with Birt–Hogg–Dubé syndrome and treated successfully, with genetic testing confirming the diagnosis.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

The treatment effectively reduces hair loss and improves hair growth with minimal side effects.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Effective monitoring and prevention strategies are needed to manage the spread of hand, foot, and mouth disease in children.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

A patient with hair loss condition grew excessive hair in areas covered by a cast.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Female pattern hair loss often starts in teenage years, reduces hair density, and can impact quality of life.

Renaming frontal fibrosing alopecia to a syndrome could improve diagnosis and treatment.

Trichoscopy is useful for diagnosing Frontal Fibrosing Alopecia.

Patients with Focal Dermal Hypoplasia often experience skin, nail, hair, and bone issues, and may benefit from calcium and vitamin D supplements.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

The review helps improve diagnosis and treatment of challenging hair disorders.

The revised BASP classification for hair loss is less accurate and harder to use but could still be a viable option.

The mutant HR bmh protein mis-localizes in cells, affecting skin and hair development.